GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Kanghua Biological Products Co Ltd (SZSE:300841) » Definitions » Short-Term Debt

Chengdu Kanghua Biological Products Co (SZSE:300841) Short-Term Debt : ¥216 Mil (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Kanghua Biological Products Co Short-Term Debt?

Chengdu Kanghua Biological Products Co's Short-Term Debt for the quarter that ended in Sep. 2024 was ¥216 Mil.

Chengdu Kanghua Biological Products Co's quarterly Short-Term Debt declined from Mar. 2024 (¥210 Mil) to Jun. 2024 (¥176 Mil) but then increased from Jun. 2024 (¥176 Mil) to Sep. 2024 (¥216 Mil).

Chengdu Kanghua Biological Products Co's annual Short-Term Debt increased from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥109 Mil) and increased from Dec. 2022 (¥109 Mil) to Dec. 2023 (¥191 Mil).

Chengdu Kanghua Biological Products Co Short-Term Debt Historical Data

The historical data trend for Chengdu Kanghua Biological Products Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Kanghua Biological Products Co Short-Term Debt Chart

Chengdu Kanghua Biological Products Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only 10.00 - - 109.30 190.91

Chengdu Kanghua Biological Products Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 125.87 190.91 210.19 176.40 216.43

Chengdu Kanghua Biological Products Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Chengdu Kanghua Biological Products Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Chengdu Kanghua Biological Products Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Kanghua Biological Products Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Kanghua Biological Products Co Ltd (SZSE:300841) » Definitions » Short-Term Debt
Comparable Companies
SHSE:688202 SHSE:688315 SZSE:300049 SHSE:600645 SHSE:688526 SHSE:603229 SHSE:688382 SZSE:000990 SHSE:600866 SZSE:002275 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 182, Beijing Road, Chengdu Economic and Technological Development Zone, Sichuan Province, Chengdu, CHN, 610100
Website
https://www.kangh.com
Chengdu Kanghua Biological Products Co Ltd is engaged in research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine (human diploid cell) for Human Use, freeze-dried - HDCV. The company's products include ACYW135 Meningococcal Polysaccharide Vaccine; and Rabies Vaccine.
Executives
Sun Wan Feng Executives
Hou Wen Li Directors, executives
Wu Wen Nian Executives
Chen Huai Gong Executives
Li Sheng You Executives
Wang Qing Han Directors, executives
Li Xiao Wen Supervisors

Chengdu Kanghua Biological Products Co Headlines

No Headlines